Miriam Lichtner | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients	THE JOURNAL OF INFECTIOUS DISEASES	2015
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy	AIDS RESEARCH AND HUMAN RETROVIRUSES	2015
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study	THE LANCET. HIV	2015
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study	PLOS MEDICINE	2015
Evaluation of blood plasmacytoid dendritic cells and inflammatory monocytes during firstwave HCV protease inhibitor therapy		2015
Positive Results of Immunoglobulin G Cytomegalovirus Serologic Testing and Risk of Severe Non-AIDS-Related Complications in HIV-Infected Patients Reply	THE JOURNAL OF INFECTIOUS DISEASES	2015
Prognostic value of the fibrosis-4 index in human immunodeficiency virus type-1 infected patients initiating antiretroviral therapy with or without hepatitis C virus	PLOS ONE	2015
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study	HIV MEDICINE	2015
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort	HIV MEDICINE	2015
Liver-related death among HIV/hepatitis C virus-co-infected individuals: Implications for the era of directly acting antivirals	AIDS	2015

Progetti di Ricerca

Marcatori di risposta e modificazioni del pattern infiammatorio in una corte di pazienti con polmonite da SARS-Cov2 sottoposti al trattamento con farmaci immunomodulanti
Ruolo dell'immunità innata nell'infezione da SARS-COV2 in una corte di pazienti con polmonite da COVID: biomarkers e correlati clinici
Risposta immune innata e immuno-attivazione T in pazienti coinfetti HIV/HCV sottoposti a farmaci ad azione diretta anti HCV (DAA) Innate immunity and immune activation in HIV/HCV coinfected subjects undergoing DAA
- Impatto dell'eradicazione di HCV nel controllo dell'immunoattivazione residua in pazienti HIV/HCV coinfetti - HCV eradication in HIV/HCV co-infected patients: impact on residual immune-activation.
Immunità mucosale nella donna HIV positiva in terapia antiretrovirale efficace: biomarcatori e correlati clinici Mucosal Immunity in HIV-1 infected women undergoing effective antiretroviral therapy: biomarkers and clinical determinants